Search filters

List of works by Antonio D'Avolio

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

scientific article published on 09 May 2020

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

scientific article published on 10 November 2010

A LC-MS method to quantify tenofovir urinary concentrations in treated patients.

scientific article

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir

scientific article published on 27 February 2013

A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease

scientific article

A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.

scientific article published in February 2008

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method

scientific article published on 07 November 2006

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma.

scientific article published on 31 January 2014

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.

scientific article published in February 2010

An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients

scientific article published in December 2008

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients

scientific article published in February 2006

Anidulafungin for Candida glabrata infective endocarditis

scientific article published on 29 May 2012

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir

scientific article published on November 2008

Calcyclin gene expression modulation by medroxyprogesterone acetate

scientific article published on July 15, 1997

Cannabinoids concentration variability in cannabis olive oil galenic preparations

scientific article

Ceftriaxone bone penetration in patients with septic non-union of the tibia

scientific article published on 15 April 2011

Cerebrospinal Fluid Abacavir Concentrations in HIV-positive Patients Following Once-daily Administration.

scientific article published on 14 February 2018

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma

scientific article published on 15 August 2017

Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".

scientific article published in April 2013

Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens

scientific article published on 29 October 2010

Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine

scientific article published in February 2004

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics

scientific article published in July 2012

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

scientific article published on 29 July 2013

Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots

scientific article published on 2 August 2016

Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.

scientific article published on 8 August 2013

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS

scientific article published on 07 August 2012

Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma

scientific article published on 9 November 2009

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients

scientific article published on 28 March 2012

Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients.

scientific article published on December 2013

Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients

scientific article published on 04 May 2018

Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

scientific article published on 7 June 2010

Differential dose adjustments of immunosuppressants after resuming boosted versus unboosted HIV-protease inhibitors postliver transplant

scientific article published on 28 July 2009

Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment

scientific article published in January 2008

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients

scientific article published on 21 January 2020

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient.

scientific article published on 4 May 2017

Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions

scientific article published on 01 May 1997

Estimating ribavirin plasma exposure: genetics or therapeutic drug monitoring?

scientific article

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection

scientific article published on 20 November 2017

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.

scientific article

Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.

scientific article published in January 2008

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions

scientific article published on 25 February 2010

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

scientific article published on 14 October 2011

HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.

scientific article published on 7 October 2007

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

scientific article published in April 2010

In vitro activity of propolis against Streptococcus pyogenes

scientific article (publication date: August 2000)

Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.

scientific article

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 21 January 2019

Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane

scientific article published on June 2013

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells

scientific article published on 5 December 2012

Is peritoneal fluid a sanctuary site for HIV?

scientific article published on 23 June 2010

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

scientific article published on 14 January 2013

L-histidine/medroxyprogesterone acetate interaction modulates human breast cancer cell growth and progestin receptor expression in vitro.

scientific article published in February 1997

LC-MS application for therapeutic drug monitoring in alternative matrices

scientific article published on 29 December 2018

Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.

scientific article published on 29 July 2009

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders

scientific article published on 26 October 2020

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

scientific article published on December 2010

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis

scientific article

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.

scientific article published on December 2012

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

scientific article published on 24 April 2009

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.

scientific article

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients

scientific article

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

scientific article published on 15 March 2011

Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.

scientific article published on 13 January 2005

Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.

scientific article published on 22 January 2011

Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors

scientific article published on 19 October 2012

Pharmacokinetics of linezolid during extracorporeal membrane oxygenation

scientific article published on 28 February 2013

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

scientific article published on 14 March 2013

Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients

article

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

scientific article published on 04 June 2011

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance

scientific article

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

scientific article published on 20 October 2010

Raltegravir penetration in seminal plasma of healthy volunteers

scientific article published on 22 March 2010

Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients

scientific article published in March 2010

Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.

scientific article published in December 2011

Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three cases

scientific article published on 03 June 2006

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes

scientific article published on 18 February 2013

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study

scientific article published on 2 December 2011

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir

scientific article published on 2 September 2013

Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.

scientific article

Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults

scientific article published on 18 July 2008

Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia

scientific article published on 20 November 2012

Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage

scientific article published in July 2011

Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting

scientific article published in November 2009

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

scientific article published on 31 January 2008

Therapeutic drug monitoring of intracellular anti-infective agents.

scientific article published on 03 April 2014

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence

scientific article published on 15 August 2018

Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.

scientific article

Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy

scientific article published on 27 March 2013

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

scientific article published on December 2010

Unexpected drug–drug interaction between tipranavir/ritonavir and enfuvirtide

scientific article published on 01 October 2006

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV

scientific article published on 25 December 2020

Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients

scientific article published on 29 March 2006